Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer
- PMID: 9171288
- DOI: 10.1006/jmbi.1997.0927
Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer
Abstract
Mutations that confer resistance to nucleoside analogs do not cluster around the deoxynucleotide triphosphate (dNTP) binding site. Instead, these mutations appear to lie along the groove in the enzyme where the template-primer binds. Based on such structural data and on complementary biochemical analyses, it has been suggested that resistance to nucleoside analogs involves repositioning of the template-primer. We have prepared mutations in HIV-2 RT that are the homologs of mutations that confer resistance to nucleoside analogs in HIV-1 RT. Analysis of the behavior of HIV-2 RT mutants (Leu74Val, Glu89Gly, Ser215Tyr, Leu74Val/Ser215Tyr and Glu89Gly/Ser215Tyr) in vitro confirms the results obtained with HIV-1 RT: resistance is a function of the length of the template overhang. These analyses also suggest that the homolog in HIV-2 RT of one of the mutations that confers resistance to AZT in HIV-1 RT (Thr215Tyr) confers resistance by repositioning of the template-primer.
Similar articles
-
Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.AIDS Res Hum Retroviruses. 1994 Aug;10(8):939-46. doi: 10.1089/aid.1994.10.939. AIDS Res Hum Retroviruses. 1994. PMID: 7529032
-
Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.J Virol. 2002 Sep;76(18):9143-51. doi: 10.1128/jvi.76.18.9143-9151.2002. J Virol. 2002. PMID: 12186898 Free PMC article.
-
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.J Mol Biol. 1994 Oct 28;243(3):369-87. doi: 10.1006/jmbi.1994.1665. J Mol Biol. 1994. PMID: 7525966 Review.
-
Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.J Biol Chem. 1998 Jun 5;273(23):14596-604. doi: 10.1074/jbc.273.23.14596. J Biol Chem. 1998. PMID: 9603976
-
Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.Antivir Ther. 2001;6 Suppl 3:25-44. Antivir Ther. 2001. PMID: 11678471 Review.
Cited by
-
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy.J Clin Microbiol. 2000 Apr;38(4):1370-4. doi: 10.1128/JCM.38.4.1370-1374.2000. J Clin Microbiol. 2000. PMID: 10747109 Free PMC article.
-
3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9518-23. doi: 10.1073/pnas.95.16.9518. Proc Natl Acad Sci U S A. 1998. PMID: 9689112 Free PMC article.
-
Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.Biochem J. 1999 Nov 15;344 Pt 1(Pt 1):85-92. Biochem J. 1999. PMID: 10548537 Free PMC article.
-
The processivity of DNA synthesis exhibited by drug-resistant variants of human immunodeficiency virus type-1 reverse transcriptase.Nucleic Acids Res. 1998 Apr 1;26(7):1713-7. doi: 10.1093/nar/26.7.1713. Nucleic Acids Res. 1998. PMID: 9512543 Free PMC article.
-
Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization.Biochem J. 1998 Feb 1;329 ( Pt 3)(Pt 3):579-87. doi: 10.1042/bj3290579. Biochem J. 1998. PMID: 9445385 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
